Peripheral nerve stimulation for saphenous neuralgia
Authors' conclusion
Our case series demonstrates the potential of PNS as a treatment for saphenous neuralgia.
Study context
- Population
- Patients with saphenous neuralgia receiving peripheral nerve stimulation (PNS) placement at a single institution, 2000–202210 with full 6-month follow-up
- Participants
- 12 patients
- Outcome
- Change in pain interference (short-form PROMIS)
- Follow-up
- 6 months
Methodological detailssingle-institution, Average follow-up 11.5 months (range 3-35 months)
- Single-institution
- Average follow-up 11.5 months (range 3-35 months)
Main finding
As reported in the abstract
Change from baseline in short-form PROMIS adjusted pain interference score (greater difference = improved pain)
Mean change from baseline (10 patients with full 6-month follow-up)
5.8
SD 6.5
Observational data: associations, not effects.
Further findings
Any improvement in symptoms
- Patients reporting any improvement
- 10 (83%)
- Patients reporting no benefit
- 2
Patient-Reported Outcome Measurement Information System (PROMIS) scores for pain, functional mobility, mood and sleep impairment
- All improved
Safety
- Patients with complications
- 4 (33%)
- Device removed
- 2
- A further patient discontinued use
Original publication
Peripheral nerve stimulation for saphenous neuralgia. Reg Anesth Pain Med. Published 2 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →